论文部分内容阅读
近年来研究表明,氧自由基在生物界和医学界方面的作用已日益受到人们的重视.而其抑制剂超氧化物歧化酶(SOD)是一种金属离子的酶蛋白,是体内自由基的清除剂.有关糖尿病患者的血清SOD水平,文献报道不一.本文用放免法对糖尿病患者分组进行了SOD测定,现将检测结果报告如下.对象和方法一、对象:(一)对照组:选自本院部分健康体检者.共30列(男13例,女17例),年龄21～45岁.(二)糖尿病组:43例(男15例,女28例),均为我院内分泌门诊与住院病人,均符合1985年WHO糖尿病诊断标准.年龄17～68岁,平均51.25岁,本组又分为两组:Ⅰ组24例,有大血管并发症或/和微血管并发症;Ⅱ组19例,无糖尿病血管并发症.
In recent years, studies have shown that oxygen free radicals in the biological world and the role of the medical profession has been increasingly valued by people, and its inhibitor superoxide dismutase (SOD) is a metal ion enzyme protein is free radical Scavenger.Diabetic patients with serum SOD levels reported in the literature vary.This paper used radioimmunoassay in patients with diabetic patients were SOD determination, the test results are reported as follows.Objects and methods A, the object: (a) control group: election A total of 30 healthy volunteers (13 males and 17 females) aged 21 to 45 years old (2) Diabetic patients: 43 cases (15 males and 28 females) Outpatients and inpatients, are in line with the WHO diagnostic criteria for diabetes in 1985. Aged 17 to 68 years old, average 51.25 years old, the group is divided into two groups: Ⅰ group of 24 patients with major vascular complications or / and microvascular complications; Ⅱ Group of 19 patients without vascular complications of diabetes.